Home » Drug Information » FDA-Approved Drugs » 1999
Medical Areas: Neurology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: GlaxoSmithKline
Approval Status: Approved June 1999
Treatment Area: Neurology
The approval of these efficacy supplements provide for the use
of Lamictal as conversion to monotherapy in adults with partial
seizures who are receiving treatment with a single enzyme-inducing
antiepileptic drug.
